Bordetella pertussis (B. pertussis) is the causative agent of whooping cough, which is a highly contagious disease in the human respiratory tract. Despite vaccination since the 1950s, pertussis remains the most prevalent vaccine-preventable disease in developed countries. A recent resurgence pertussis is associated with the expansion of B. pertussis strains with a novel allele for the pertussis toxin (ptx) promoter ptxP3 in place of resident ptxP1 strains. The recent expansion of ptxP3 strains suggests that these strains carry mutations that have increased their fitness. Compared to the ptxP1 strains, ptxP3 strains produce more Ptx, which results in increased virulence and immune suppression. In this study, we investigated the contribution of gene expression changes of various genes on the increased fitness of the ptxP3 strains. Using genome-wide gene expression profiling, we show that several virulence genes had higher expression levels in the ptxP3 strains compared to the ptxP1 strains. We provide the first evidence that wildtype ptxP3 strains are better colonizers in an intranasal mouse infection model. This study shows that the ptxP3 mutation and the genetic background of ptxP3 strains affect fitness by contributing to the ability to colonize in a mouse infection model. These results show that the genetic background of ptxP3 strains with a higher expression of virulence genes contribute to increased fitness.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679012PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066150PLOS

Publication Analysis

Top Keywords

ptxp3 strains
28
increased fitness
16
strains
13
gene expression
12
ptxp1 strains
12
ptxp3
9
genome-wide gene
8
pertussis
8
bordetella pertussis
8
resurgence pertussis
8

Similar Publications

Pertussis (or whooping cough) has experienced a global resurgence despite widespread vaccine efforts. In China, the incidence of pertussis has rapidly increased, particularly following the COVID-19 pandemic. Whole-genome sequencing analysis was performed on 60 strains isolated in Beijing from 2020 to 2023, and the sequences were compared with those of 635 strains from China and 943 strains from other countries.

View Article and Find Full Text PDF

Macrolide-resistant strain identified during an ongoing epidemic, Finland, January to October 2024.

Euro Surveill

December 2024

Finnish Reference Laboratory for Diphtheria and Pertussis, Institute of Biomedicine, University of Turku, Turku, Finland.

Since April 2024, a pertussis epidemic has been ongoing in Finland with 2,215 notified cases by end October. Of them, 30.1% (n = 667) were aged 10-14 years.

View Article and Find Full Text PDF

Unlabelled: Whooping cough (pertussis) has re-emerged despite high vaccine coverage in Australia and many other countries worldwide, partly attributable to genetic adaptation of the causative organism, to vaccines. Therefore, genomic surveillance has become essential to monitor circulating strains for these genetic changes. However, increasing uptake of PCR for the diagnosis of pertussis has affected the availability of cultured isolates for typing.

View Article and Find Full Text PDF

Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China.

Clin Microbiol Infect

November 2024

Laboratory of Microbiology, Department of Clinical Laboratory, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China; Nosocomial Infection Control Department, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China. Electronic address:

Objectives: China has experienced a notable upsurge in pertussis cases post-COVID-19, alongside an age shift to older children, increased vaccine escape, and a notable rise in the prevalence of macrolide-resistant Bordetella pertussis. Here, we present a genomic epidemiological investigation of these events.

Methods: We performed a retrospective observational study using culture-positive B pertussis isolated in Shanghai, China, from 2016 to 2024.

View Article and Find Full Text PDF

Emergence of Erythromycin-Resistant and Pertactin- and Filamentous Hemagglutinin-Deficient Strains - Beijing, China, 2022-2023.

China CDC Wkly

May 2024

National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Article Synopsis
  • * Recent findings show that all isolated Pertussis strains were resistant to erythromycin, with several strains lacking key immunogenic components.
  • * The rise of strains lacking effective immune targets suggests a need to rethink vaccination strategies, while high levels of antibiotic resistance complicate treatment options.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!